[Epidemiological studies of the association between dyslipidemia and Alzheimer's disease].

Alzheimer's disease (AD), as the representative type of dementia among neurodegenerative diseases, has become a major challenge in the field of global public health. Dyslipidemia is considered an acquired risk factor for AD, and both are progressive diseases with long developmental periods, making dyslipidemia a potential predictor of future AD occurrence. Therefore, preventing dyslipidemia is of great significance for the prevention and treatment of AD. Given the global epidemiological background of AD, this article aims to systematically review the association between dyslipidemia and AD, providing theoretical support for the prevention and control of both conditions. 阿尔茨海默病（AD）作为神经退行性疾病中具代表性的痴呆类型，已成为全球公共卫生领域的重要挑战。血脂异常被认为是AD的一个获得性危险因素，两者均是具有长发展期特点的进行性疾病，这使得血脂异常可成为未来AD发生的潜在预测因子，预防血脂异常的发生对AD的防治具有重要意义。本文基于AD全球流行病学背景，系统综述血脂异常与AD的关联，为血脂异常合并AD的防控提供理论支持。.